RARRES2 and gastric cancer: These observations were supported by a second study reporting increased levels of circulating chemerin in gastric cancer patients, which also identified this adipokine as an independent predictor for five-year mortality (odds ratio (OR), 2.718; p = 0.005) and adverse event (OR, 2.982; p = 0.003) of gastric cancer.